Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, FogPharma is raising $178,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Gregory Verdine played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About FogPharma
FogPharma was born from the scientific and entrepreneurial vision of founder Greg Verdine, a pioneer in the discovery and development of new drug classes that drug the undruggable. FogPharmas cell-penetrating miniproteins (CPMPs) are a broad new class of medicines that can drug targets beyond the reach of conventional therapeutics.

To learn more about FogPharma, visit http://www.fogpharma.com/

Contact:
Gregory Verdine, Chief Executive Officer
617-945-9510

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved